major sellers, page-87

Anteo's rules for Directors dealing in shares are shown on their own website, under the Corporate Governance tab:


7. SECURITIES DEALING POLICY
Introduction
Anteo Diagnostics Limited (the "Company") aims to ensure that all Directors, officers and
employees of the Company and its associated entities (the "Group") are aware of its policy
regarding these individuals trading in the Company's Securities1. This policy conforms to Principle
3 of the ASX Corporate Governance Councils Corporate Governance Principles and
Recommendations.
Background
Directors, Senior Executives and employees (and their respective associates) of the Group are
subject to the insider trading requirements of the Corporations Act in relation to any dealing in
Securities.
Policy on Trading in Anteo Diagnostics Limited Securities by Directors and Senior
Executives
Directors, Senior Executives and Senior Members of staff ("Officers"2) of the Group shall not trade
in Securities of the Company where they are in possession of information which could be
considered Price Sensitive Information3, being such information in regard to the Company which is
not generally known to the market. (Section 1002G of the Corporations Act). While there may be "windows of opportunity" for Officers to trade in the Company's Securities,
it is the overriding issue of possession of Price Sensitive Information, which must always be
considered by each Officer on every occasion when it is intended to trade in the Company's
Securities
It is generally held that announcements by the Company of half yearly and yearly results and
the Annual General Meeting of the Company afford Officers periods in which to trade in the
Company's Securities. At such times there is a release of information to the public generally.
Bearing in mind the above it is proposed that Officers would not be expected to trade except as
follows:
Following announcement of half yearly and yearly results to the Australian Stock
Exchange or other announcement of Price Sensitive Information from three days
after the announcement to a maximum of thirty days from the date of the
announcement and
Following the Company's Annual General Meeting from the day after the
announcement to a maximum of thirty days from the date of the Annual General
Meeting and
During the period of a new issue in the new Securities during the offer period and
Pursuant to an approved Executive or Employee Share Plan where Securities may
be accepted but not sold
At all times other than those specified above:
Officers must notify the Chairman firstly requesting authority to trade ahead of
trading in the Company's Securities and
Direct reportees of the Chief Executive Officer should notify the Chief Executive
Officer or Company Secretary ahead of trading in the Company's Securities and
Employees participating in the Executive Share Option Plan should notify the
Company Secretary ahead of trading in Company Securities
Staff who do not fall into the above categories should refer to the Policy on Trading
in Anteo Diagnostics Limited Securities by Employees (below)
Confirmation of trading in the above circumstances must be made to the Company
Secretary
Notification of Interests and Trading
In order to comply with ASX Continuous Disclosure requirements all Directors must inform the
Company Secretary of the following:
Upon appointment - Interests in the Companys securities at appointment date
Following trading - Changes to interests as a result of trading in the Companys securities
within four days of the appointment or the trade taking place.

1 "Securities" includes, shares, debentures, convertible notes and other options over Securities
2 "Officer" includes a spouse or partner, relative, friend, and any trustee of a trust or family company of that Officer
3 "Price Sensitive Information" is information that, is not generally known to the market which if released to the market,
would have an effect on the market price of the Companys Securities (whether increasing or decreasing that price) - (Section 1002G of the Corporations Act).